Oleic acid and angiotensin II induce a synergistic mitogenic response in vascular smooth muscle cells

Hypertension

Volumn 31, Issue 4, 1998, Pages 978-985

  Lu, Gang ^a   Meier, Kathryn E ^a   Jaffa, Ayad A ^a   Rosenzweig, Steven A ^a   Egan, Brent M ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Angiotensin II; Antisense; Extracellular signal regulated kinases; Muscle; Oleic acid; Oligonucleotides; Protein kinase C; Receptors, angiotensin; Smooth; Vascular

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANTISENSE OLIGODEOXYNUCLEOTIDE; LOSARTAN; MITOGEN ACTIVATED PROTEIN KINASE; OLEIC ACID; PROTEIN KINASE C; THYMIDINE;

ANIMAL CELL; ARTICLE; CELL COUNT; DRUG ANTAGONISM; DRUG POTENTIATION; HYPERTENSION; MITOGENESIS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE;

EID: 0031923705     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.31.4.978     Document Type: Article

References (44)

1. Stern M, Haffner S. Body fat distribution and hyperinsulinemia as risk factors for diabetes and cardiovascular diseases. Arteriosclerosis. 1986; 6:123-129.
2. Gillum R. The association of body fat distribution with hypertension, hypertensive heart disease, CHD, diabetes and cardiovascular risk factors in men and women ages 18-79 years. J Chronic Dis. 1987;40:421-428.
3. Peiris A, Sothmann M, Hoffmann R, Hennes M, Wilson C, Gustafson A, Kissebah A. Adiposity, fat distribution and cardiovascular risk. Ann Intern Med. 1989;110:867-872.
4. Reaven GM. Hollenbeck C, Jeng CY, Wu MS, Chen YD. Measurement of plasma glucose, free fatty acid, lactate and insulin for 24 h in patients with NIDDM. Diabetes. 1988;37:1020-1024.
5. Jensen MD, Haymond MW, Rizza RA, Cryer PE, Miles JM. Influence of body fat distribution on free fatty acid metabolism in obesity. J Clin Invest. 1989;83:1168-1173.
6. Egan BM, Hennes MMI, O'Shaughnessy IM, Stepniakowski KT, Kissebah AH, Goodfriend TL. Obesity hypertension is more closely related to impairment of insulin's fatty acid than glucose lowering action. Hypertension. 1996;27(pt 2):723-728.
7. Davda RK, Stepniakowski KT, Lu G, Ullian ME, Goodfriend TL, Egan BM. Oleic acid inhibits endothelial nitric oxide synthase by a protein kinase C-independent mechanism. Hypertension. 1995;26:764-770.
8. 2+ and phospholipids. J Biol Chem. 1986;261:15424-15429.
9. Khan WA, Blobe G, Halpern A, Taylor W, Wetsel WC, Burns D, Loomis C, Hannun YA. Selective regulation of protein kinase C isoenzymes by oleic acid in human platelets. J Biol Chem. 1993;268:5063-5068.
10. Dzau VJ, Gibbons GH. Endothelium and growth factors in vascular remodeling of hypertension. Hypertension 1991;18(suppl III): III-115-III-121.
11. Yong VW. Proliferation of human and mouse astrocytes in vitro: signalling through the protein kinase C pathway. J Neurol Sci. 1992;111: 92-103.
12. Lu G, Morinelli TA, Meier KE, Rosenzweig SA, Egan BM. Oleic acid-induced mitogenic signaling in vascular smooth muscle cells: a role for protein kinase C. Circ Res. 1996;79:611-618.
13. Egan BM, Stepniakowski K, Goodfriend TL. Renin and aldosterone are higher and the hyperinsulinemic effect of salt restriction are greater in subjects with risk factor clustering. Am J Hypertens. 1994;7:886-893.
14. Goodfriend TL, Egan BM, Stepniakowski K, Ball D. Relationships among plasma aldosterone, HDL cholesterol, and insulin in humans. Hypertension. 1995;25:30-36.
15. Schelling P, Fischer H, Ganten D. Angiotensin and cell growth: a link to cardiovascular hypertrophy? J Hypertens. 1991;9:3-15.
16. 2+-sensitive protein kinases in the response of hepatocytes to angiotensin II and vasopressin. J Biol Chem. 1984;259:3283-3292.
17. Jones LG, Ella KM, Bradshaw CD, Cause KC, Dey M, Wisehart-Johnson AE, Spivey EC, Meier KE. Activation of mitogen-activated protein kinases and phospholipase D in A7r5 vascular smooth muscle cells. J Biol Chem. 1994;269:23790-23799.
18. Cobb MH, Boulton TG, Robbins DJ. Extracellular signal-regulated kinases. Cell Regulation. 1991;2:965-978.
19. Davis RJ. The mitogen-activated protein kinase signal transduction pathway. J Biol Chem. 1993;268:14553-14556.
20. 2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest. 1995;95:651-657.
21. Chamley-Campbell JH, Campbell GR, Ross R. The smooth muscle cell in culture. Physiol Rev. 1979;59:1-61.
22. Goodfriend TL, Ball DL. Fatty acid effect on angiotensin receptors. J Cardiovasc Pharmacol. 1986;8:1276-1283.
23. Sale EM, Atkinson PGP, Sale GJ. The requirement of MAP kinase for the differentiation of fibroblasts to adipocytes, for insulin activation of p90 S6 kinase and for insulin or serum stimulation of DNA synthesis. EMBO J. 1995;14:674-684.
24. Glennon PE, Kaddoura S, Sale EM, Sale GJ, Fuller SJ, Sugden PH. Depletion of mitogen-activated protein kinase using an antisense oligode-oxynucleotide approach downregulates the phenylephrine-induced hypertrophic response in rat cardiac myocytes. Circ Res. 1996;78:954-961.
25. Graf K, Xi XP, Yang D, Fleck E, Hsueh WA, Law RE. Mitogen-activated protein kinase activation is involved in platelet-derived growth factor-directed migration by vascular smooth muscle cells. Hypertension. 1997;29(pt 2):334-339.
26. Taylor SS, Radzio-Andzelm E, Hunter T. How do protein kinases discriminate between serine/threonine and tyrosine? Structural insights from the insulin receptor protein-tyrosine kinase. FASEB J. 1995;9:1255-1266.
27. Payne DM, Rossomando PM, Erickson AK, Her JH, Shabanowitz J, Hunt DF, Weber MJ, Sturgill TW. Identification of the regulatory phosphorylation sites in PP42/mitogen-activated protein kinase (MAP kinase). EMBO J. 1991;10:885-892.
28. 1A receptor via a G protein βγ-subunit-initiated pathway. Biochemistry. 1996;35:13716-13722.
29. 2-terminal kinase/stress-activated protein kinase by insulin. Biochemistry. 1996;35:8769-8775.
30. Oliver WJ, Cohen EL, Neel JV. Blood pressure, sodium intake, and sodium related hormones in the Yanomano Indians, a "no-salt" culture. Circulation. 1975;52:146-151.
31. Chinn RH, Düsterdieck G. The response of blood pressure to infusion of angiotensin II: relation to plasma concentrations of renin and angiotensin II. Clin Sci. 1972;72:489-504.
32. 3H] DUP 753, a highly potent and specific radioligand for the angiotensin II-1 receptor subtype. Biochem Biophys Res Commun. 1990;172:1195-1202.
33. Timmermans PBMWM, Wong PC, Chiu AT, Herblin WF, Benfield P, Carinin DJ, Lee RJ, Wexler RR, Saye JAM, Smith RD. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev. 1993; 45:205-251.
34. Berra E, Diaz-Meco MT, Dominguez I, Municio MM, Sanz L, Lozano J, Chapkin RS, Moscat J. Protein kinase C ζ isoform is critical for mitogenic signal transduction. Cell. 1993;74:555-563.
35. Haller H, Lindschau C, Quass P, Distler A, Luft FC. Differentiation of vascular smooth muscle cells and the regulation of protein kinase C-α. Circ Res. 1995;76:21-29.
36. Tan Y, Rouse J, Zhang A, Cariati S, Cohen P, Comb MJ. FGF and stress regulate CREB and ATF-1 via a pathway involving p38 MAP kinase and MAPKAP kinase-2. EMBO J. 1996;15:4629-4642.
37. Derijard B, Raingeaud J, Barrett T, Wu IH, Han J, Ulevitch RJ, Davis RJ. Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms. Science. 1995;267:682-685.
38. Sanchez I, Hughes RT, Mayer BJ, Yee K, Woodgett JR, Avruch J, Kyriakis JM, Zon LI. Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun. Nature. 1994;372:794-798.
39. Meier R, Rouse J, Cuenda A, Nebreda AR, Cohen P. Cellular stresses and cytokines activate multiple mitogen-activated-protein kinase kinase homologues in PC12 and KB cells. Eur J Biochem. 1996;236:796-805.
40. Banno Y, Tamiya-Koizumi K, Oshima H, Morikawa A, Yoshida S, Nozawa Y. Nuclear ADP-ribosylation factor (AFR)-, and oleate-dependent phospholipase D (PLD) in rat liver cells: increasing of AFR-dependent PLD activity in regenerating liver cells. J Biol Chem. 1997; 272:5208-5213.
41. Cohen MV, Liu Y, Liu GS, Wang P, Weinbrenner C, Cordis GA, Das DK, Downey JM. Phospholipase D plays a role in ischemic preconditioning in rabbit heart. Circulation. 1996;94:1713-1718.
42. Owens GK, Geisterfer AAT, Yang YWH, Komoriya A. Transforming growth factor-β induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells. J Cell Biol. 1988;107:771-780.
43. Gibbons GH, Pratt RE, Dzau VJ. Vascular smooth muscle cell hypertrophy vs hyperplasia: autocrine transforming growth factor-β1 expression determines growth response to angiotensin II. J Clin Invest. 1992;90: 456-461.
44. Koibuchi Y, Lee WS, Gibbons GH, Pratt RE. Role of transforming growth factor-β1 in the cellular growth response to angiotensin II. Hypertension. 1993;21:1046-1050.